CH

Cherry Huang

Intl Regulatory

Xiamen Amoytop Biotech Co Ltd

Your Profile

Country
China
Department
Regulatory Affairs/QA/QC
Company Type
Distributor/Import ExportManufacturer/Innovator
Industry Sector
Biopharmaceutical

Offering:

Offering: Product Categories
Biopharmaceuticals
Offering: Markets Active In
AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesSouth America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Offering: Product Categories
BiopharmaceuticalsBiosimilarsBiotechnology and related specialitiesCell & Gene therapy

Interested In:

Interested In: Product Categories
Biopharmaceuticals
Interested In: Product Categories
BiopharmaceuticalsCMC

Is member of

Xiamen Amoytop Biotech Co. Ltd

is attending

Drug Repurposing: A More Efficient Approach to Drug Development?

Reenal Gandhi · Aptar Pharma

Risk Mitigation Through Physical and Chemical Testing: Lyophilized Drug Product Case Study

Application of Advanced Proteomic and Mass Spectrometry Technologies to Enhance the Efficacy of production of Biopharmaceuticals

Increasing Efficiencies in Bioprocess Development and Manufacturing through Digital Process Development

How will the New Administration Impact the US Pharma Market?

Log in

See all the content and easy-to-use features by logging in or registering!